Effects of adding esaxerenone to calcium channel blocker in patients with essential hypertension.
Not Applicable
Recruiting
- Conditions
- essential hypertension
- Registration Number
- JPRN-UMIN000037721
- Lead Sponsor
- Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients taking antihypertensive drugs other than calcium channel blocker during the last 8 weeks. Patients with systolic blood pressure>=160 mmHg and/or diastolic blood pressure>=100 mmHg. Patients with severe renal dysfunction (eGFR <30 mL/min/1.73 m2). Patients with unstable angina. Patients with a history of myocardial infarction or stroke within 24 weeks. Patients with severe liver dysfunction. Pregnant or lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in blood pressure, pulse rate, serum levels of potassium and creatinine, and eGFR
- Secondary Outcome Measures
Name Time Method